Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.
The American Society of Clinical Oncology annual meeting in Chicago last year. One of the conference’s coveted headliners this year will be a presentation of a clinical trial conducted only in China.
A Bristol Myers Squibb plant that makes cancer drugs was the only manufacturer in the U.S. recognized for innovation by the World Economic Forum this year.